<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Sarcoma

Research    Honors    Sarcoma

Two New Grants Help CU Researchers Test New Sarcoma Treatments

While many cancer types have added new treatments including genetically targeted drugs and immunotherapies, treatment for the rare types of cancer known as sarcomas have remained largely the same for about two decades. Now, two grants to University of Colorado Cancer Center researchers from the Sarcoma Foundation of America hope to change this.


Author Cancer Center | Publish Date June 22, 2020
Full Story

CU Cancer Center In the News

OncLive

Dr. Schenk on the Evolving Treatment Landscape in Lung Cancer

news outletOncLive
Publish DateAugust 25, 2020

Erin Schenk, MD, PhD, University of Colorado Cancer Center member, discusses the rapidly evolving treatment landscape in lung cancer.

Full Story
OncLive

Dr. Bunn on Targeting HER3 in NSCLC

news outletOncLive
Publish DateAugust 18, 2020

Paul A. Bunn, Jr, MD, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado, and a 2014 Giant of Cancer Care® in Lung Cancer, discusses potentially targeting HER3 in non–small cell lung cancer (NSCLC).

Full Story
Oncology Learning Network

Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer

news outletOncology Learning Network
Publish DateAugust 10, 2020

“Current guidelines recommend a 28-day course of enoxaparin for thromboprophylaxis after surgery for gynecologic cancer,” wrote Saketh R. Guntupalli, Director of the Division of Gynecologic Oncology, University of Colorado School of Medicine, and colleagues.

Full Story
OncLive

Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC

news outletOncLive
Publish DateJuly 27, 2020

Paul A. Bunn, Jr, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado and a 2014 Giant of Cancer Care® in Lung Cancer, highlights encouraging data with fam-trastuzumab deruxtecan-nxki (Enhertu) in HER2-mutant non–small cell lung cancer (NSCLC).

Full Story